Drug Treatment of Dyslipoproteinemia
- 1 June 1990
- journal article
- review article
- Published by Elsevier in Endocrinology and Metabolism Clinics of North America
- Vol. 19 (2) , 345-360
- https://doi.org/10.1016/s0889-8529(18)30329-3
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Efficacy and long-term adverse effect pattern of lovastatinThe American Journal of Cardiology, 1988
- Lovastatin for Lowering Cholesterol Levels in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Lipid-Lowering DrugsDrugs, 1987
- Studies on the mechanism of action of probucolThe American Journal of Cardiology, 1986
- Effects of probucol on xanthomata regression in familial hypercholesterolemiaThe American Journal of Cardiology, 1986
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein CatabolismNew England Journal of Medicine, 1980